BD Launching BDProbeTec Chlamydia/Gonorrhea Test This Fall Outside U.S.
This article was originally published in The Gray Sheet
Becton Dickinson plans to roll out the BDProbeTec ET (energy transfer) in vitro test for molecular diagnosis of Neisseria gonorrheae and Chlamydia trachomatis this fall outside the U.S., the company reported Aug. 4 at the American Association for Clinical Chemistry Conference in Chicago.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.